Fecal Microbiota Characteristics of Patients with Colorectal Adenoma Detected by Screening: A Population-based Study

EBioMedicine

Volumn 2, Issue 6, 2015, Pages 597-603

  Goedert, James J ^a   Gong, Yangming ^b   Hua, Xing ^a   Zhong, Huanzi ^c   He, Yimin ^c   Peng, Peng ^b   Yu, Guoqin ^a   Wang, Wenjing ^b   Ravel, Jacques ^d   Shi, Jianxin ^a   Zheng, Ying ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SHANGHAI MUNICIPAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c BGI SHENZHEN   (China)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer screening; China; Colorectal adenoma; Colorectal cancer; Feces; Microbiota

Indexed keywords

RNA 16S;

ADULT; AGED; ARTICLE; CANCER SCREENING; CASE CONTROL STUDY; CLINICAL TRIAL; COLON POLYP; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; DNA EXTRACTION; DNA ISOLATION; DNA PURIFICATION; ENTERITIS; FECES MICROFLORA; FEMALE; FOLLICULAR LYMPHOMA; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY ANALYSIS; SEQUENCE ANALYSIS; ADENOMA; COLORECTAL NEOPLASMS; DNA SEQUENCE; EARLY CANCER DIAGNOSIS; FECES; GENETICS; INTESTINE FLORA; MASS SCREENING; MICROBIOLOGY; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC;

ADENOMA; AGED; BASE SEQUENCE; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; RNA, RIBOSOMAL, 16S; ROC CURVE; SEQUENCE ANALYSIS, DNA;

EID: 84949627020     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2015.04.010     Document Type: Article

References (36)

1. Ahlquist D.A., Zou H., Domanico M., Mahoney D.W., Yab T.C., Taylor W.R., Butz M.L., Thibodeau S.N., Rabeneck L., Paszat L.F., et al. Next-generation stool DNA test accurately detects colorectal cancer and large adenomas. Gastroenterology 2012, 142:248-256. (quiz e225-246).
2. Ahn J., Sinha R., Pei Z., Dominianni C., Wu J., Shi J., Goedert J.J., Hayes R.B., Yang L. Human gut microbiome and risk for colorectal cancer. J. Natl. Cancer Inst. 2013, 105:1907-1911.
3. Beaugerie L., Svrcek M., Seksik P., Bouvier A.M., Simon T., Allez M., Brixi H., Gornet J.M., Altwegg R., Beau P., et al. Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease. Gastroenterology 2013, 145:166-175. (e168).
4. Brim H., Yooseph S., Zoetendal E.G., Lee E., Torralbo M., Laiyemo A.O., Shokrani B., Nelson K., Ashktorab H. Microbiome analysis of stool samples from African Americans with colon polyps. PLoS One 2013, 8:e81352.
5. Caporaso J.G., Kuczynski J., Stombaugh J., Bittinger K., Bushman F.D., Costello E.K., Fierer N., Pena A.G., Goodrich J.K., Gordon J.I., et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 2010, 7:335-336.
6. Carmona F.J., Azuara D., Berenguer-Llergo A., Fernandez A.F., Biondo S., de Oca J., Rodriguez-Moranta F., Salazar R., Villanueva A., Fraga M.F., et al. DNA methylation biomarkers for noninvasive diagnosis of colorectal cancer. Cancer Prev. Res. (Phila.) 2013, 6:656-665.
7. Castellarin M., Warren R.L., Freeman J.D., Dreolini L., Krzywinski M., Strauss J., Barnes R., Watson P., Allen-Vercoe E., Moore R.A., et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 2012, 22:299-306.
8. Chen H.M., Yu Y.N., Wang J.L., Lin Y.W., Kong X., Yang C.Q., Yang L., Liu Z.J., Yuan Y.Z., Liu F., et al. Decreased dietary fiber intake and structural alteration of gut microbiota in patients with advanced colorectal adenoma. Am. J. Clin. Nutr. 2013, 97:1044-1052.
9. Collins D., Hogan A.M., Winter D.C. Microbial and viral pathogens in colorectal cancer. Lancet Oncol. 2011, 12:504-512.
10. Fadrosh D.W., Ma B., Gajer P., Sengamalay N., Ott S., Brotman R.M., Ravel J. An improved dual-indexing approach for multiplexed 16S rRNA gene sequencing on the Illumina MiSeq platform. Microbiome 2014, 2:6.
11. Flanagan L., Schmid J., Ebert M., Soucek P., Kunicka T., Liska V., Bruha J., Neary P., Dezeeuw N., Tommasino M., et al. Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome. Eur. J. Clin. Microbiol. Infect. Dis. 2014, 33:1381-1390.
12. Goedert J.J., Hua X., Yu G., Shi J. Diversity and composition of the adult fecal microbiome associated with history of cesarean birth or appendectomy: analysis of the American Gut Project. EBioMedicine 2014, 1:167-172.
13. Goedert J.J., Sampson J.N., Moore S.C., Xiao Q., Xiong X., Hayes R.B., Ahn J., Shi J., Sinha R. Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis 2014, 35:2089-2096.
14. Imperiale T.F., Ransohoff D.F., Itzkowitz S.H., Levin T.R., Lavin P., Lidgard G.P., Ahlquist D.A., Berger B.M. Multitarget stool DNA testing for colorectal-cancer screening. N. Engl. J. Med. 2014, 370:1287-1297.
15. Kostic A.D., Gevers D., Pedamallu C.S., Michaud M., Duke F., Earl A.M., Ojesina A.I., Jung J., Bass A.J., Tabernero J., et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 2012, 22:292-298.
16. Kuipers E.J., Rosch T., Bretthauer M. Colorectal cancer screening-optimizing current strategies and new directions. Nat. Rev. Clin. Oncol. 2013, 10:130-142.
17. Lieberman D. Screening for colorectal cancer in individuals at average risk: current methods and emerging issues. JAMA Intern. Med. 2014, 174:10-11.
18. Lieberman D.A., Rex D.K., Winawer S.J., Giardiello F.M., Johnson D.A., Levin T.R. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2012, 143:844-857.
19. Loberg M., Kalager M., Holme O., Hoff G., Adami H.O., Bretthauer M. Long-term colorectal-cancer mortality after adenoma removal. N. Engl. J. Med. 2014, 371:799-807.
20. McCoy A.N., Araujo-Perez F., Azcarate-Peril A., Yeh J.J., Sandler R.S., Keku T.O. Fusobacterium is associated with colorectal adenomas. PLoS One 2013, 8:e53653.
21. Meester R.G., Doubeni C.A., Lansdorp-Vogelaar I., Goede S.L., Levin T.R., Quinn V.P., Ballegooijen M., Corley D.A., Zauber A.G. Colorectal cancer deaths attributable to nonuse of screening in the United States. Ann. Epidemiol. 2015, 25:208-213. (e201).
22. Mira-Pascual L., Cabrera-Rubio R., Ocon S., Costales P., Parra A., Suarez A., Moris F., Rodrigo L., Mira A., Collado M.C. Microbial mucosal colonic shifts associated with the development of colorectal cancer reveal the presence of different bacterial and archaeal biomarkers. J. Gastroenterol. 2015, 50:167-179.
23. Qin J., Li Y., Cai Z., Li S., Zhu J., Zhang F., Liang S., Zhang W., Guan Y., Shen D., et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012, 490:55-60.
24. Sanapareddy N., Legge R.M., Jovov B., McCoy A., Burcal L., Araujo-Perez F., Randall T.A., Galanko J., Benson A., Sandler R.S., et al. Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans. ISME J. 2012, 6:1858-1868.
25. Schwabe R.F., Jobin C. The microbiome and cancer. Nat. Rev. Cancer 2013, 13:800-812.
26. Sears C.L., Pardoll D.M. Perspective: alpha-bugs, their microbial partners, and the link to colon cancer. J. Infect. Dis. 2011, 203:306-311.
27. Shen X.J., Rawls J.F., Randall T., Burcal L., Mpande C.N., Jenkins N., Jovov B., Abdo Z., Sandler R.S., Keku T.O. Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes 2010, 1:138-147.
28. Tjalsma H., Boleij A., Marchesi J.R., Dutilh B.E. A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat. Rev. Microbiol. 2012, 10:575-582.
29. Wang Q., Garrity G.M., Tiedje J.M., Cole J.R. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 2007, 73:5261-5267.
30. Wang T., Cai G., Qiu Y., Fei N., Zhang M., Pang X., Jia W., Cai S., Zhao L. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J. 2012, 6:320-329.
31. Warren R.L., Freeman D.J., Pleasance S., Watson P., Moore R.A., Cochrane K., Allen-Vercoe E., Holt R.A. Co-occurrence of anaerobic bacteria in colorectal carcinomas. Microbiome 2013, 1:16.
32. Weir T.L., Manter D.K., Sheflin A.M., Barnett B.A., Heuberger A.L., Ryan E.P. Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One 2013, 8:e70803.
33. Wu N., Yang X., Zhang R., Li J., Xiao X., Hu Y., Chen Y., Yang F., Lu N., Wang Z., et al. Dysbiosis signature of fecal microbiota in colorectal cancer patients. Microb. Ecol. 2013, 66:462-470.
34. Zackular J.P., Rogers M.A., Ruffin M.T.T., Schloss P.D. The human gut microbiome as a screening tool for colorectal cancer. Cancer Prev. Res. (Phila.) 2014, 7:1112-1121.
35. Zauber A.G., Winawer S.J., O'Brien M.J., Lansdorp-Vogelaar I., van Ballegooijen M., Hankey B.F., Shi W., Bond J.H., Schapiro M., Panish J.F., et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N. Engl. J. Med. 2012, 366:687-696.
36. Zeller G., Tap J., Voigt A.Y., Sunagawa S., Kultima J.R., Costea P.I., Amiot A., Bohm J., Brunetti F., Habermann N., et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol. Syst. Biol. 2014, 10:766.